1. Home
  2. BWAY vs UMAC Comparison

BWAY vs UMAC Comparison

Compare BWAY & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • UMAC
  • Stock Information
  • Founded
  • BWAY 2003
  • UMAC 2019
  • Country
  • BWAY Israel
  • UMAC United States
  • Employees
  • BWAY N/A
  • UMAC N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • UMAC
  • Sector
  • BWAY Health Care
  • UMAC
  • Exchange
  • BWAY Nasdaq
  • UMAC Nasdaq
  • Market Cap
  • BWAY 280.7M
  • UMAC 267.7M
  • IPO Year
  • BWAY 2019
  • UMAC 2024
  • Fundamental
  • Price
  • BWAY $14.97
  • UMAC $15.54
  • Analyst Decision
  • BWAY Strong Buy
  • UMAC Strong Buy
  • Analyst Count
  • BWAY 2
  • UMAC 3
  • Target Price
  • BWAY $18.00
  • UMAC $19.33
  • AVG Volume (30 Days)
  • BWAY 61.1K
  • UMAC 3.8M
  • Earning Date
  • BWAY 11-11-2025
  • UMAC 11-13-2025
  • Dividend Yield
  • BWAY N/A
  • UMAC N/A
  • EPS Growth
  • BWAY 679.98
  • UMAC N/A
  • EPS
  • BWAY 0.11
  • UMAC N/A
  • Revenue
  • BWAY $46,084,000.00
  • UMAC $7,701,550.00
  • Revenue This Year
  • BWAY $335.63
  • UMAC $86.94
  • Revenue Next Year
  • BWAY $22.10
  • UMAC $118.95
  • P/E Ratio
  • BWAY $55.30
  • UMAC N/A
  • Revenue Growth
  • BWAY 26.50
  • UMAC 279.38
  • 52 Week Low
  • BWAY $7.84
  • UMAC $1.28
  • 52 Week High
  • BWAY $17.00
  • UMAC $23.62
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 48.22
  • UMAC 65.27
  • Support Level
  • BWAY $14.65
  • UMAC $11.82
  • Resistance Level
  • BWAY $15.60
  • UMAC $17.48
  • Average True Range (ATR)
  • BWAY 0.67
  • UMAC 1.51
  • MACD
  • BWAY -0.11
  • UMAC 0.24
  • Stochastic Oscillator
  • BWAY 29.79
  • UMAC 67.26

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About UMAC Unusual Machines Inc. Common Stock

Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.

Share on Social Networks: